These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1145 related articles for article (PubMed ID: 19626372)

  • 21. Prognostic factors in node-negative intrahepatic cholangiocarcinoma with special reference to angiogenesis.
    Shirabe K; Shimada M; Tsujita E; Aishima S; Maehara S; Tanaka S; Takenaka K; Maehara Y
    Am J Surg; 2004 Apr; 187(4):538-42. PubMed ID: 15041507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The survival outcome and prognostic factors for middle and distal bile duct cancer following surgical resection.
    Choi SB; Park SW; Kim KS; Choi JS; Lee WJ
    J Surg Oncol; 2009 May; 99(6):335-42. PubMed ID: 19226533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Operations for intrahepatic cholangiocarcinoma: single-institution experience of 158 patients.
    Lang H; Sotiropoulos GC; Sgourakis G; Schmitz KJ; Paul A; Hilgard P; Zöpf T; Trarbach T; Malagó M; Baba HA; Broelsch CE
    J Am Coll Surg; 2009 Feb; 208(2):218-28. PubMed ID: 19228533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serosal invasion in TNM staging of mass-forming intrahepatic cholangiocarcinoma.
    Uenishi T; Yamazaki O; Yamamoto T; Hirohashi K; Tanaka H; Tanaka S; Hai S; Kubo S
    J Hepatobiliary Pancreat Surg; 2005; 12(6):479-83. PubMed ID: 16365823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognosis of perihilar cholangiocarcinoma: hilar bile duct cancer versus intrahepatic cholangiocarcinoma involving the hepatic hilus.
    Sano T; Shimada K; Sakamoto Y; Ojima H; Esaki M; Kosuge T
    Ann Surg Oncol; 2008 Feb; 15(2):590-9. PubMed ID: 18057991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of nodal status for perihilar cholangiocarcinoma: location, number, or ratio of involved nodes.
    Aoba T; Ebata T; Yokoyama Y; Igami T; Sugawara G; Takahashi Y; Nimura Y; Nagino M
    Ann Surg; 2013 Apr; 257(4):718-25. PubMed ID: 23407295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Major hepatic resection for hilar cholangiocarcinoma: analysis of 46 patients.
    Rea DJ; Munoz-Juarez M; Farnell MB; Donohue JH; Que FG; Crownhart B; Larson D; Nagorney DM
    Arch Surg; 2004 May; 139(5):514-23; discussion 523-5. PubMed ID: 15136352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma.
    Shimada M; Yamashita Y; Aishima S; Shirabe K; Takenaka K; Sugimachi K
    Br J Surg; 2001 Nov; 88(11):1463-6. PubMed ID: 11683741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index.
    Shirabe K; Mano Y; Taketomi A; Soejima Y; Uchiyama H; Aishima S; Kayashima H; Ninomiya M; Maehara Y
    Ann Surg Oncol; 2010 Jul; 17(7):1816-22. PubMed ID: 20135355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma: a Western experience.
    Portolani N; Baiocchi GL; Coniglio A; Piardi T; Grazioli L; Benetti A; Ferrari Bravo A; Giulini SM
    Ann Surg Oncol; 2008 Jul; 15(7):1880-90. PubMed ID: 18443881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
    Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
    Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathological confirmation of para-aortic lymph node status as a potential criterion for the selection of intrahepatic cholangiocarcinoma patients for radical resection with regional lymph node dissection.
    Nakayama T; Tsuchikawa T; Shichinohe T; Nakamura T; Ebihara Y; Hirano S
    World J Surg; 2014 Jul; 38(7):1763-8. PubMed ID: 24378552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term survival after extended surgical resection of intrahepatic cholangiocarcinoma with extensive lymph node metastasis.
    Asakura H; Ohtsuka M; Ito H; Kimura F; Ambiru S; Shimizu H; Togawa A; Yoshidome H; Kato A; Miyazaki M
    Hepatogastroenterology; 2005; 52(63):722-4. PubMed ID: 15966191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgical treatment of intrahepatic cholangiocarcinoma--a single center experience.
    Lanthaler M; Biebl M; Strasser S; Weissenbacher A; Falkeis C; Margreiter R; Nehoda H
    Am Surg; 2010 Apr; 76(4):411-7. PubMed ID: 20420253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between microvessel count and postoperative survival in patients with intrahepatic cholangiocarcinoma.
    Nanashima A; Shibata K; Nakayama T; Tobinaga S; Araki M; Kunizaki M; Takeshita H; Hidaka S; Sawai T; Nagayasu T; Tagawa T
    Ann Surg Oncol; 2009 Aug; 16(8):2123-9. PubMed ID: 19434454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
    Steven K; Poulsen AL
    J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Biopathological characteristics of hilar cholangiocarcinoma and the clinical significance].
    Yu WL; Zhang YJ; Dong H; Yu H; Xian ZH; Wu MC; Cong WM
    Zhonghua Wai Ke Za Zhi; 2009 Aug; 47(15):1162-6. PubMed ID: 20021908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of systemic inflammation on outcome following resection for intrahepatic cholangiocarcinoma.
    Gomez D; Morris-Stiff G; Toogood GJ; Lodge JP; Prasad KR
    J Surg Oncol; 2008 May; 97(6):513-8. PubMed ID: 18335453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.
    Ito F; Agni R; Rettammel RJ; Been MJ; Cho CS; Mahvi DM; Rikkers LF; Weber SM
    Ann Surg; 2008 Aug; 248(2):273-9. PubMed ID: 18650638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Major hepatectomy for hilar cholangiocarcinoma type 3 and 4: prognostic factors and longterm outcomes.
    Baton O; Azoulay D; Adam DV; Castaing D
    J Am Coll Surg; 2007 Feb; 204(2):250-60. PubMed ID: 17254929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 58.